The Long Shot: The Inside Story of the Race to Vaccinate Britain

Kate Bingham and Tim Hames

Hardcover

Regular price $28.95
Regular price Sale price $28.95
Shipping calculated at checkout.

Items available in store will have a number before "in stock"

Availability: In stock
SKU: 9780861545643
Regular price $28.95
Regular price Sale price $28.95
How Covid-19 vaccines went from the laboratory to people's arms - the inside story of an extraordinary national campaign against all odds

The Sunday Times bestseller

FT Book of the Year

On 3 April 2020, Kate Bingham was told that the likelihood of any Covid-19 vaccine working was 15% at best. But on 8 December 2020, the first NHS patient received a vaccine. Now nearly every adult in Britain has had a jab, lockdowns have ended and we can finally live with Covid. What lies behind this staggering success story?

From a cottage miles away from Westminster, Bingham juggled vaccine suppliers, Whitehall, the media circus - and her daughter's exams. Political manoeuvring, miscommunications and administrative meddling nearly jeopardised the project. But perseverance paid off.

Catapulted into a national crisis, Bingham's eclectic team secured the first vaccine doses administered in the West and saved thousands of lives in the UK as new variants struck. This is an unmissable insider view into how the Vaccine Taskforce beat the odds and delivered the scientific miracle we all waited for.

Publisher: ONEWorld Publications
Published: 03/21/2023
Pages: 336
Weight: 1.2lbs
Size: 9.20h x 6.40w x 1.30d
ISBN: 9780861545643

About the Author
Dame Kate Bingham served as the Chair of the UK Vaccine Taskforce, on a seven-month unpaid secondment, steering a team of experts to deliver the world's fastest Covid-19 vaccination programme. She is Managing Partner at life sciences venture capital firm SV Health Investors where she co-leads SV's biotech franchise which has a long history of developing transformational new medicines. She was awarded a DBE for her services as Chair of the UK Vaccine Taskforce.